Storia in 2 fonti

What it will take for India to lead global biotech manufacturing value chain

This article is authored by Dhananjay Singh, managing director, Merck Life Science & head, Discovery Solutions, India.

Raccontata da

fiercebiotech.com

hindustantimes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

hindustantimes.comStai leggendo8 g fa

What it will take for India to lead global biotech manufacturing value chain

This article is authored by Dhananjay Singh, managing director, Merck Life Science & head, Discovery Solutions, India.

originale

fiercebiotech.com9 g fa

‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D wins

Indian pharma majors are advancing 10+ novel assets, with AbbVie paying $700M to Glenmark for a myeloma antibody. The shift from generics to discovery shows $40-50B firms now fund biotech; early wins reshape global pharma competition and India's ecosystem.

Leggi questa versione →

Timeline cronologica

giovedì 23 luglio 2026·fiercebiotech.com
‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D wins
Despite its status as the “pharmacy of the world,” India’s deep life sciences roots have traditionally been based in manufacturing and replication. | A string of recent wins on…
venerdì 24 luglio 2026·hindustantimes.com
What it will take for India to lead global biotech manufacturing value chain
This article is authored by Dhananjay Singh, managing director, Merck Life Science & head, Discovery Solutions, India.